Adult

Homology Medicines to Participate at Upcoming Conferences

Retrieved on: 
Thursday, October 6, 2022

BEDFORD, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, announced today participation at the following conferences.

Key Points: 
  • BEDFORD, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, announced today participation at the following conferences.
  • Additional programs focus on metachromatic leukodystrophy (MLD), paroxysmal nocturnal hemoglobinuria (PNH) and other diseases.
  • Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a focus on rare diseases.
  • Homology believes its initial clinical data and compelling preclinical data, scientific and product development expertise and broad intellectual property position the Company as a leader in genetic medicines.

Walgreens and Lexie Hearing Announce Availability of Over-the-Counter (OTC) Hearing Aids at Walgreens Stores Nationwide

Retrieved on: 
Thursday, October 6, 2022

Walgreens and Lexie Hearing today announced Lexie Lumen hearing aids will be available OTC at Walgreens stores nationwide for adults ages 18 and older with mild-to-moderate hearing loss starting October 17.

Key Points: 
  • Walgreens and Lexie Hearing today announced Lexie Lumen hearing aids will be available OTC at Walgreens stores nationwide for adults ages 18 and older with mild-to-moderate hearing loss starting October 17.
  • View the full release here: https://www.businesswire.com/news/home/20221006005319/en/
    Walgreens and Lexie Hearing announced Lexie Lumen hearing aids will be available over the counter at Walgreens stores nationwide for adults with mild-to-moderate hearing loss starting October 17.
  • Starting October 17, Lexie Lumen hearing aids can be purchased at Walgreens stores nationwide, including Puerto Rico, for $799.
  • Once purchased, Lexie Hearing offers customers a complete hearing solution, including a professional-quality hearing check, hearing aids customized to their unique hearing profile, and access to hearing experts through video or voice calls.

Tickets Still Available to the 2022 Food Network New York City Wine & Food Festival Presented By Capital One

Retrieved on: 
Thursday, October 6, 2022

The Food Network New York City Wine & Food Festival presented by Capital One is hosted by Gods Love We Deliver with 100% of the Festivals net proceeds helping to support New Yorkers facing severe illness.

Key Points: 
  • The Food Network New York City Wine & Food Festival presented by Capital One is hosted by Gods Love We Deliver with 100% of the Festivals net proceeds helping to support New Yorkers facing severe illness.
  • Over the past 15 years, the Festival has generated more than $14 million for its charitable partners.
  • Southern Glazers Wine & Spirits is the exclusive provider of wine and spirits at the Festival.
  • In November 2021, BizBash named the Festival the #1 Food & Restaurant Industry event in New York for the ninth year in a row.

'Hands' Has Legs - Dianña's Song Hands Still Charting Top 30 Billboard After 10 Weeks

Retrieved on: 
Thursday, October 6, 2022

LOS ANGELES, Oct. 6, 2022 /PRNewswire/ -- 'Hands' by Dianña has spent seven of its ten weeks on the Adult Contemporary charts inside the top 20, reported her label Billeegee Productions, which is quite a feat for a newcomer. As is being the #1 independent artist on the Adult Contemporary charts for five of those weeks, including knocking none other than Rock n Roll Hall of Famer Joan Jett from the #1 position. 

Key Points: 
  • Diana has also released an acoustic version of 'Hands' as an Official Music Video on YouTube.
  • In addition to Adult Contemporary radio 'Hands' is also playing on dozens of Country radio stations.
  • "I could just see the type of life he had led by looking at the scars and texture in his hands," Diana said.
  • Check out "Hands" on Spotify: https://spoti.fi/3vtgYwn
    Connect with Diana on all her social media and streaming platforms via her Linktr.ee: https://linktr.ee/diannacountry
    Watch the Hands Acoustic video: https://tinyurl.com/mrn9hwmt

Qualigen Therapeutics to Present Two Posters at the National Cancer Institute Fourth RAS Initiative Symposium

Retrieved on: 
Thursday, October 6, 2022

Activating mutations in one of the three human RAS gene isoforms (KRAS, HRAS, or NRAS) are present in about one-fourth of all cancers.

Key Points: 
  • Activating mutations in one of the three human RAS gene isoforms (KRAS, HRAS, or NRAS) are present in about one-fourth of all cancers.
  • For example, mutant KRAS is found in 98% of pancreatic ductal adenocarcinomas, 52% of colon cancers, and 32% of lung adenocarcinomas.
  • Our investigational QN-247 compound inhibits nucleolin, a key multi-functional regulatory protein that is overexpressed in cancer cells; QN-247 may thereby be able to inhibit the cells proliferation.
  • This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of 12 Week Safety Data from ENVASARC Phase 2 Pivotal Trial - Trial to Proceed as Planned

Retrieved on: 
Thursday, October 6, 2022

Accrual continues to exceed projections and we remain on track for the Independent Data Monitoring Committee to review interim efficacy data in the fourth quarter of this year, said James Freddo, M.D., TRACONs Chief Medical Officer.

Key Points: 
  • Accrual continues to exceed projections and we remain on track for the Independent Data Monitoring Committee to review interim efficacy data in the fourth quarter of this year, said James Freddo, M.D., TRACONs Chief Medical Officer.
  • Envafolimab (KN035), a single-domain antibody against PD-L1 invented by Alphamab Oncology and licensed by TRACON, is the first approved subcutaneously injected PD-(L)1 inhibitor.
  • The primary endpoint is objective response rate by central review with duration of response a key secondary endpoint.
  • TRACON is actively seeking additional corporate partnerships through a profit-share or revenue-share partnership, or through franchising TRACONs product development platform.

Edgewise Therapeutics to Present on EDG-5506 for Becker and Duchenne Muscular Dystrophy (BMD, DMD) at the 27th International Hybrid Annual Congress of the World Muscle Society

Retrieved on: 
Thursday, October 6, 2022

The conference will take place at the Halifax Convention Centre in Halifax, Nova Scotia, from October 11-15, 2022.

Key Points: 
  • The conference will take place at the Halifax Convention Centre in Halifax, Nova Scotia, from October 11-15, 2022.
  • The symposium will be streamed to the virtual element of the event and available for replay via the conference platform.
  • The Edgewise symposium presentation and posters will be available on the Edgewise website when they are presented.
  • EDG-5506 is an orally administered small molecule designed to address muscle damage induced by mechanical stress in dystrophinopathies including DMD and BMD.

Six Flags Entertainment to Provide World-Class Employee Education Benefits Through Workforce Edge

Retrieved on: 
Thursday, October 6, 2022

Six Flags employees will be able to take advantage of the benefits offered to them as a result of the Workforce Edge partnership which began on October 3, 2022.

Key Points: 
  • Six Flags employees will be able to take advantage of the benefits offered to them as a result of the Workforce Edge partnership which began on October 3, 2022.
  • Through this partnership, Six Flags has secured a spot as a market leader in employee benefits, positioning it as an attractive employer in the amusement park entertainment space and helping ensure it maintains a skilled workforce.
  • Workforce Edge serves as a solution to help employers offer their workforce higher education options that are relevant, innovative and affordable.
  • Since launching, Workforce Edge has partnered with 45 industry-leading employers to help administer education benefits.

Caring Senior Service debuts on the Franchise Times Top 500

Retrieved on: 
Thursday, October 6, 2022

SAN ANTONIO, Oct. 6, 2022 /PRNewswire/ -- Caring Senior Service, a non-medical home care company with more than 50 locations throughout the United States, today announced it has made its debut on the Franchise Times Top 500, an exclusive annual ranking of the largest franchise systems by global systemwide sales.

Key Points: 
  • "Earning a spot on the Franchise Times list shows the achievements of our business model, our people, our technology and our best-in-class training and support," said Caring Senior Service founder and CEO Jeff Salter.
  • The Franchise Times Top 500 is an annual ranking of the 500 largest U.S.-based franchise systems.
  • Caring Senior Service is a non-medical home care services company based in San Antonio, Texas.
  • The Franchise Times Top 500 is the only ranking by systemwide sales and units of the largest 500 U.S.-based franchise brands.

BMO offers free access to Headspace to North American employees and their families

Retrieved on: 
Thursday, October 6, 2022

Headspace offers a range of tools for managing stress, sleep, focus and more.

Key Points: 
  • Headspace offers a range of tools for managing stress, sleep, focus and more.
  • "BMO continues to make bold investments in our total rewards offering, consistent with our Purpose to support our employees in business and life.
  • "Headspace is a leading platform that is easy to access at any time from anywhere, providing tangible resources to employees that they can share with their friends and family."
  • This new partnership with Headspace helps remove some of the barriers that employees may face in prioritizing their mental health.